Chinatsu Makiyama
Chinatsu Makiyama publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Surgery, on topics such as Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies and Helicobacter pylori-related gastroenterology studies.
- World rank
- #3,369,804 of 7,710,434 ranked researchers
- Rank in Japan
- #80,682 of 383,136
- Works
- 19
- Citations
- 268
- Citations per work
- 14.1
What does Chinatsu Makiyama research?
Chinatsu Makiyama's work is mostly in Medicine (82%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1682.5%
- Medicine1682.5%
- Everything else210.5%
- Life Sciences17.0%
- 1Pulmonary and Respiratory Medicine32% of their works
- 2Oncology23% of their works
- 3Surgery19% of their works
- 4Molecular Biology7% of their works
- 5Gastroenterology5% of their works
- 6Pathology and Forensic Medicine4% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Colorectal Cancer Treatments and Studies
- Helicobacter pylori-related gastroenterology studies
- Metastasis and carcinoma case studies
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cancer Treatment and Pharmacology
- Cancer Immunotherapy and Biomarkers
- Gastrointestinal Tumor Research and Treatment
Which keywords describe Chinatsu Makiyama's research?
The keywords of their largest research topics: Chemotherapy, Gastric Cancer, Endoscopic Resection, Molecular Characterization, Cetuximab, KRAS Mutations, Prognostic Factors and Surgical Management.
- Sunitinib
- Taxanes
- Immune Checkpoint Blockade
- Metastatic Carcinomas
- Cholangiocarcinoma
- Inflammation
- Surgical Management
- KRAS Mutations
- Molecular Characterization
- Gastric Cancer
- Chemotherapy
- Endoscopic Resection
- Cetuximab
- Prognostic Factors
- Helicobacter pylori
- Biliary Tract Cancer
- Lung Tumors
- Chemotherapy-Induced Peripheral Neuropathy
- PD-1 and PD-L1
- Imatinib Mesylate
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Chemotherapy192 topics
- Gastric Cancer182 topics
- Endoscopic Resection131 topic
- Molecular Characterization131 topic
- Cetuximab61 topic
- KRAS Mutations61 topic
- Prognostic Factors62 topics
- Surgical Management62 topics
- Helicobacter pylori51 topic
- Inflammation51 topic
- Biliary Tract Cancer41 topic
- Cholangiocarcinoma41 topic
- Lung Tumors41 topic
- Metastatic Carcinomas41 topic
- Chemotherapy-Induced Peripheral Neuropathy31 topic
- Immune Checkpoint Blockade31 topic
- PD-1 and PD-L131 topic
- Taxanes31 topic
- Imatinib Mesylate21 topic
- Sunitinib21 topic
Where does Chinatsu Makiyama work?
Chinatsu Makiyama's main affiliation in the publication record is Kyushu Hospital, Japan.
How many publications and citations does Chinatsu Makiyama have?
OpenAlex counts 19 works and 268 citations for Chinatsu Makiyama, an h-index of 6, ranking #3,369,804 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Chinatsu Makiyama. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.